Mor G - Search Results

1

Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer.

Cocco E, Casagrande F, Bellone S, Richter CE, Bellone M, Todeschini P, Holmberg JC, Fu HH, Montagna MK, Mor G, Schwartz PE, Arin-Silasi D, Azoudi M, Rutherford TJ, Abu-Khalaf M, Pecorelli S, Santin AD. Cocco E, et al. Among authors: mor g. BMC Cancer. 2010 Jul 2;10:349. doi: 10.1186/1471-2407-10-349. BMC Cancer. 2010. PMID: 20598131 Free PMC article.

2

The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas.

Gutierrez LS, Eliza M, Niven-Fairchild T, Naftolin F, Mor G. Gutierrez LS, et al. Among authors: mor g. Breast Cancer Res Treat. 1999 Apr;54(3):245-53. doi: 10.1023/a:1006102601215. Breast Cancer Res Treat. 1999. PMID: 10445423

3

Absence of estrogen receptor-beta expression in metastatic ovarian cancer.

Rutherford T, Brown WD, Sapi E, Aschkenazi S, Muñoz A, Mor G. Rutherford T, et al. Among authors: mor g. Obstet Gynecol. 2000 Sep;96(3):417-21. doi: 10.1016/s0029-7844(00)00917-0. Obstet Gynecol. 2000. PMID: 10960636 Free article.

4

Hormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells.

Song J, Rutherford T, Naftolin F, Brown S, Mor G. Song J, et al. Among authors: mor g. Mol Hum Reprod. 2002 May;8(5):447-55. doi: 10.1093/molehr/8.5.447. Mol Hum Reprod. 2002. PMID: 11994542

5

Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells.

Aschkenazi S, Straszewski S, Verwer KM, Foellmer H, Rutherford T, Mor G. Aschkenazi S, et al. Among authors: mor g. Biol Reprod. 2002 Jun;66(6):1853-61. doi: 10.1095/biolreprod66.6.1853. Biol Reprod. 2002. PMID: 12021072

6

Regulation of Fas ligand expression by estrogen in normal ovary.

Sapi E, Brown WD, Aschkenazi S, Lim C, Munoz A, Kacinski BM, Rutherford T, Mor G. Sapi E, et al. Among authors: mor g. J Soc Gynecol Investig. 2002 Jul-Aug;9(4):243-50. J Soc Gynecol Investig. 2002. PMID: 12113885

7

Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes.

Mor G, Sapi E, Abrahams VM, Rutherford T, Song J, Hao XY, Muzaffar S, Kohen F. Mor G, et al. J Immunol. 2003 Jan 1;170(1):114-22. doi: 10.4049/jimmunol.170.1.114. J Immunol. 2003. PMID: 12496390

8

Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer.

Wang S, Pudney J, Song J, Mor G, Schwartz PE, Zheng W. Wang S, et al. Among authors: mor g. Gynecol Oncol. 2003 Feb;88(2):108-17. doi: 10.1016/s0090-8258(02)00008-2. Gynecol Oncol. 2003. PMID: 12586588

9

Phenoxodiol--an isoflavone analog--induces apoptosis in chemoresistant ovarian cancer cells.

Kamsteeg M, Rutherford T, Sapi E, Hanczaruk B, Shahabi S, Flick M, Brown D, Mor G. Kamsteeg M, et al. Among authors: mor g. Oncogene. 2003 May 1;22(17):2611-20. doi: 10.1038/sj.onc.1206422. Oncogene. 2003. PMID: 12730675

10

Low-grade endometrial stromal sarcoma: hormonal aspects.

Chu MC, Mor G, Lim C, Zheng W, Parkash V, Schwartz PE. Chu MC, et al. Among authors: mor g. Gynecol Oncol. 2003 Jul;90(1):170-6. doi: 10.1016/s0090-8258(03)00258-0. Gynecol Oncol. 2003. PMID: 12821359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

381 results

Search Page